Stockreport

Sanofi gains EU approval recommendation for Scarlisa subcutaneous version [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF a positive opinion regarding approval of a subcutaneous formulation of Sanofi's ( SNY ) Scarlisa (isatuximab) administered via on-body injection. If approved, Scarlisa [Read more]